NTS bacteremia is the most common cause of community-acquired bacteremia in many parts of sub-Saharan Africa 1 , and NTS coinfection has been associated with high malaria mortality 2 . The association of NTS infection with hemolysis is well established in humans with malaria (especially severe malarial anemia) 3, 4 and sickle cell disease 5 and in mice with hemolysis resulting from rodent malaria infection [6] [7] [8] , treatment with phenylhydrazine or erythrocytetargeting antibodies, or red blood cell enzyme defects [9] [10] [11] . It has been assumed that hemolysis-induced macrophage dysfunction is responsible for this phenomenon, although there is no direct evidence that macrophages are the primary refuge of NTS in vivo in the context of hemolysis 7, 8, 10 .
Hemolysis results in liberation of heme, leading to expression of the inducible isoform of HO (HO-1) 12 , which degrades heme to biliverdin, carbon monoxide and iron 13 . Heme is pro-oxidant, induces neutrophil migration and activates the neutrophil oxidative burst [14] [15] [16] , but HO-1 (and its products) are essential in cytoprotection (reviewed in ref. 17) , as evidenced by the severe susceptibility to oxidative stress of mice and humans with HO-1 deficiency [18] [19] [20] . HO-1 induction has been shown to protect against infectious, inflammatory and hypoxicischemic insults in mice (reviewed in ref. 21 ) and has been linked to modulation of malarial pathogenesis 22 and sickle cell disease 23 . Recently, in mice, induction of HO-1 has been proposed as a tolerance mechanism in severe malaria [24] [25] [26] and polymicrobial sepsis 27 : HO-1 lessens heme-mediated tissue damage and enhances survival without reducing pathogen load. A key cytoprotective effect of HO-1, and thus a likely explanation for its ability to confer tolerance, is its ability to limit the production of damaging reactive oxygen species (ROS, reviewed in ref. 17) . However, ROS are crucial for resistance to certain pathogens, including Salmonella species 28 , and this raises the possibility that tolerance of one pathogen may sometimes come at the price of loss of resistance to another. We hypothesized that liberation of heme by intravascular hemolysis may lead to HO-1 induction and impairment of resistance to NTS, with increased bacterial replication and mortality.
RESULTS
Hemolysis and heme impair resistance to S. typhimurium bacteremia To determine whether heme liberated by hemolysis impairs resistance to NTS infection, we compared survival and bacterial loads after intraperitoneal infection of C57BL/6 mice with GFP-expressing S. typhimurium with or without preceding Py17XNL co-infection, phenylhydrazine (PHZ) or hemin treatment. Py17XNL infection of C57BL/6 mice caused a self-resolving infection; parasitemia peaked at 20-30% and was accompanied by progressive hemolytic anemia (Fig. 1a) . By contrast, PHZ treatment caused acute hemolysis (Fig. 1b) . In both cases, plasma heme concentrations were markedly increased and similar to concentrations achieved 12 h after injection of hemin (Fig. 1c) , but without depletion of haptoglobin or hemopexin ( Supplementary Fig. 1a,b) . Survival of Salmonella-infected mice was dramatically shortened by prior Py17XNL infection, PHZ or hemin treatment (Fig. 1d) and was significantly shorter in PHZ-and hemin-treated mice (16 h ) than in Py17XNL co-infected mice (18 h) (P < 0.01, log-rank Mantel Cox test). PHZ, hemin and Py17XNL did not cause any mortality in the absence of S. typhimurium infection (data not shown).
Decreased survival of malaria-infected, PHZ-treated or hemintreated mice after S. typhimurium infection was accompanied by higher bacterial loads in whole blood, spleen, liver and bone marrow (Fig. 1e) , and bacteremia was much more pronounced; immediately before death (that is, 16-18 h after infection in Py17XNL-infected, PHZ-or hemin-treated mice and 72 h after infection in control mice), bacterial loads in the blood of infected or treated mice were proportionately higher, and bacterial loads in liver and spleen proportionately lower (Fig. 1e) , than in control mice (Fig. 1f) .
S. typhimurium localize in granulocytes following hemolysis
By flow cytometry, we identified GFP + (S. typhimurium-containing) cells in blood, spleen and bone marrow. In the blood of Py17NXL-infected mice, and of PHZ-or hemin-treated mice, just before death, we found salmonellae predominantly in Gr-1 hi cells (Fig. 2a) , and they were enriched in this cell population compared to the bacteria in control (PBS-treated) mice (Fig. 2b) . The proportion of all GFP + Gr-1 hi cells in blood, spleen and bone marrow (Fig. 2c) correlated with the bacterial load determined by culture (Fig. 1e,f) . We identified the Gr-1 hi cells as granulocytes (Ly6G + F4/80 − CD115 − ; Supplementary  Fig. 2a,b) . Almost all GFP + cells were CD115 − (Fig. 2d) ; moreover, S. typhimurium infection caused a higher proportion of Gr-1 lo CD115 − blood leukocytes (Fig. 2e) , suggesting that immature granulocytes are mobilized from the bone marrow to the peripheral blood during infection 29 . In support of this, blood films from Py17XNL-infected and PHZ-or hemin-treated mice 18 h after S. typhimurium infection showed numerous neutrophils containing S. typhimurium, and many of these neutrophils had immature nuclear morphology (Fig. 2f) .
In contrast, neutrophils from PBS-treated mice showed mature nuclear morphology and did not contain S. typhimurium.
The accumulation of GFP + bacteria in granulocytes was not simply due to failure of bacterial uptake by monocytes and macrophages, as the proportion of GFP + cells in the spleen that were either monocytes or macrophages (F4/80 lo CD11b hi and F4/80 hi CD11b lo , respectively) did not differ between Py17XNL-infected or PHZ-or hemin-treated mice and those treated with PBS alone (Supplementary Fig. 2c ).
Py17XNL inhibits granulocyte oxidative burst and bacterial killing
As there is no obvious defect in uptake of S. typhimurium by macrophages and monocytes after hemolysis or hemin treatment, accumulation of S. typhimurium in blood granulocytes may result from impaired bacterial killing or a more permissive intracellular environment for bacterial replication. To investigate these possibilities, we isolated CD11b + cells from blood of Py17XNL-infected and uninfected mice and compared their ability to phagocytose and kill S. typhimurium. Neither flow cytometric analysis of GFP + cells nor quantitative culture (in a gentamicin protection assay) revealed any differences in the rates of phagocytosis of S. typhimurium between neutrophils or monocytes or between cells from malaria-infected or uninfected mice (Fig. 3a,b) ; we confirmed the intracellular location of GFP + bacteria by confocal microscopy ( Supplementary Fig. 3a,b) . However, when we lysed cells after 2 h in the gentamicin protection assay and enumerated live bacteria by culture, the live bacterial recovery from cells from Py17XNL-infected mice was significantly higher than from control mice (Fig. 3b) , indicating considerable impairment of intracellular killing of S. typhimurium by cells from Py17XNL-infected mice.
As HO-1 reduces the production of ROS [30] [31] [32] [33] , and as phagocyte NADPH oxidase is essential for resistance to S. typhimurium early in infection 28 , we investigated whether Py17XNL infection impairs the granulocyte oxidative burst. Using oxidation of dihydrorhodamine to its fluorescent derivative rhodamine as a readout for oxidative burst 34 , we observed progressive suppression of the phorbol myristate acetate (PMA)-induced oxidative burst of blood granulocytes during infection (Fig. 3c) . Granulocytes were not simply refractory to PMA stimulation, as PMA-induced degranulation (assessed by surface CD11b expression 35 ) was actually enhanced 14 and 21 d after malaria infection (Fig. 3d) . In contrast, blood granulocytes isolated 24 h after PHZ or hemin treatment did not differ from those of control mice in oxidative burst capacity, degranulation, ex vivo phagocytosis or killing of S. typhimurium (Fig. 3c,d and Supplementary Fig. 3c,d ).
Hemolysis induces dysfunctional granulocyte mobilization
Accumulation of heme after PHZ-mediated hemolysis or hemin administration is faster than during Py17XNL infection. Heme directly induces neutrophil migration and ROS production 16 , whereas the subsequent HO-1 induction in myeloid cells can suppress maturation and oxidative burst 30, 33 . As HO-1 is induced in bone marrow by hemolysis 26 , we wondered whether the chronic hemolysis associated with Py17XNL infection might induce HO-1 expression in immature bone marrow myeloid cells, suppress their oxidative burst capacity as they mature and allow gradual accumulation of dysfunctional cells in the circulation, as opposed to acute hemolysis (induced by PHZ), which may both activate the oxidative burst of circulating granulocytes and mobilize functionally immature bone marrow granulocytes, resulting in heterogeneous oxidative burst activity of blood granulocytes (as suggested by Fig. 3c ). In mice, granulocyte maturation in bone marrow is characterized by increasing expression of Gr-1 (ref. 29) . Gr-1 hi cells are mature neutrophils, and Gr-1 lo cells are immature granulocytes and granulocyte progenitors; the Gr-1 int (intermediate) compartment contains a mixture of cell types. Generation of an oxidative burst is restricted to a functionally mature subpopulation of cells 36 in the Gr-1 hi , and to a lesser extent the Gr-1 int , compartments ( Supplementary Fig. 4 ).
Treatment with hemin or PHZ and Py17XNL infection all caused marked depletion of Gr-1 hi cells from bone marrow ( Fig. 3e and Supplementary Fig. 5 ). For PHZ and hemin treatment, loss of Gr-1 hi cells from bone marrow was accompanied by an increase in granulocytes in peripheral blood ( Supplementary Fig. 5 ), confirming the effect of free heme in mobilization of granulocytes from bone marrow to the periphery. Although the proportion of circulating granulocytes did not increase during Py17XNL infection, granulocyte mobilization might have been obscured by an overall increase in leukocyte count or granulocyte redistribution (for example, from blood to the spleen) 37 . S. typhimurium infection caused granulocyte mobilization in PBS-treated mice and markedly exacerbated the granulocyte mobilization in Py17XNL-infected and PHZ-or hemin-treated mice ( Fig. 3e and Supplementary Fig. 5 ), consistent with the presence of immature granulocytes in blood (Fig. 2e) . To confirm that hemolysis and bacterial challenge did indeed result in granulocytes with reduced oxidative burst activity entering the circulation, we assessed the oxidative burst of circulating granulocytes. Eight hours after S. typhimurium infection, the oxidative burst response to PMA was enhanced in PBS-treated mice (presumably due to priming 38 ), but the oxidative burst capacity was markedly lower in PHZ-treated mice (Fig. 3f) . Finally, we investigated whether maturation of the oxidative burst in bone marrow granulocytes was also impaired. On day 14 of Py17XNL infection, and 18 h after PHZ or hemin treatment, there was a clear quantitative defect in the PMA-induced oxidative burst of Gr-1 hi cells (Fig. 3g) , evident as an increase in the proportion of cells with low oxidative burst capacity and a decrease in the proportion of cells with high burst capacity (Fig. 3h) , compared to the PBS control.
Together, these data indicate that intravascular heme (released during hemolysis) mobilizes granulocytes from bone marrow and simultaneously impairs development of their oxidative burst. Thus, granulocytes entering the circulation in response to subsequent infection are able to phagocytose S. typhimurium but, owing to their reduced oxidative burst capacity, fail to kill them, providing instead a niche for bacterial replication and dissemination.
HO-1 is induced in immature bone marrow myeloid cells
Given that the cytoprotective effects of HO-1, and of the heme degradation product, carbon monoxide, have been attributed to inhibition of ROS production 17,39 , we wondered whether suppression of the granulocyte oxidative burst correlated with HO-1 induction during granulopoiesis. As expected 25, 40 , PHZ treatment and Py17XNL infection led to systemic induction of HO-1 ( Supplementary Fig. 6a-c) . HO-1 was consistently induced in peripheral blood monocytes by Py17XNL, PHZ and hemin, but only (to a modest extent) by hemin in circulating granulocytes and by Py17XNL in the nonmyeloid population (Supplementary Fig. 6d) .
In bone marrow of untreated, uninfected mice, HO-1 is expressed mainly in F4/80 + cells (Fig. 4a) , presumably macrophages and monocytes. However, in hemin-treated and PHZ-treated mice, there was a significant increase in the proportion of HO-1 + bone marrow cells, especially in the Gr-1 lo/− F4/80 − compartment (Fig. 4a,b) . There was a small but significant increase in the proportion of HO-1 + Gr-1 lo F4/80 − cells in Py17XNL-infected mice (Fig. 4b) but no overall increase in bone marrow HO-1 + cells, probably owing to mobilization of F4/80 + cells from bone marrow to blood and spleen 37, 41 ( Supplementary Fig. 7) . The Gr-1 lo/− F4/80 − compartment contains have not yet been defined, we assessed HO-1 expression in the granulocyte macrophage progenitor (GMP) population, which is proximal to the myeloblast in the myeloid differentiation pathway 42 . Py17XNL, PHZ and hemin all caused significant induction of HO-1 even at this very early stage of development (Fig. 4c) . Thus, malaria infection, hemolysis and hemin treatment all induce HO-1 expression in the earliest stages of granulocyte development and thereby impair subsequent functional maturation of these cells.
HO inhibition restores resistance to S. typhimurium
To test the hypothesis that HO-1 impairs resistance of Py17XNL-infected mice to S. typhimurium bacteremia, we pretreated mice with the competitive HO inhibitor tin protoporphyrin IX (SnPP). Treatment of Py17XNL-infected mice with SnPP for 48 h before S. typhimurium infection reduced bacterial loads in blood, spleen and liver to levels not significantly different from those in PBS treated mice (Fig. 5a) . SnPP treatment had no effect on bacterial load in mice without Py17XNL infection (Fig. 5a ) or on parasitemia in Py17XNL-infected mice (Fig. 5b) but very effectively prevented accumulation of GFP + S. typhimurium within granulocytes in Py17XNL-infected mice (Fig. 5c,d ). SnPP also partially restored resistance to S. typhimurium when administered 2 h before PHZ treatment (Fig. 5a,c,d ) and prolonged the survival of Py17XNL-infected or PHZ-treated mice after S. typhimurium infection (Fig. 5e) . Cobalt protoporphyrin (CoPP), which induces HO-1 in the absence of hemolysis or free heme 43 , did not impair resistance to S. typhimurium 16 h after infection (Fig. 5a) . Thus, both heme and HO-1 are necessary for impairment of resistance to S. typhimurium caused by Py17XNL or PHZ hemolysis, and inhibition of HO abrogates this effect. Inhibition of HO by SnPP did not restore the oxidative burst of Gr-1 hi bone marrow granulocytes in Py17XNL-infected or PHZ-treated mice (Fig. 5f) , presumably owing to enhanced mobilization of mature Gr-1 hi cells (Fig. 5g) as a result of greater heme accumulation ( Fig. 3e and Supplementary Fig. 5 ).
However, SnPP did reverse the accumulation of granulocytes with low-level oxidative burst activity in the bone marrow of Py17XNL-infected and PHZ-treated mice (Fig. 5h) , indicating that inhibition of HO restores normal development of the oxidative burst in maturing bone marrow granulocytes.
DISCUSSION
Understanding the etiology of NTS septicemia in individuals with malaria and other hemolytic disorders may lead to new strategies for reducing morbidity and mortality. To reflect the clinical association between NTS septicemia and severe malarial anemia 3,4 , we have used a model in which malaria infection causes progressive hemolysis, eventually resulting in severe (but not lethal) anemia, to assess the impact of S. typhimurium co-infection on disease. We have shown that loss of resistance to S. typhimurium requires hemolytic release of cell-free heme and subsequent induction of HO-1 and that inhibition of HO-1 reverses this susceptibility to NTS. Thus, although HO-1 is essential for tolerance to the cytotoxic effects of free heme, reducing disease severity without altering pathogen load [24] [25] [26] [27] , HO-1-mediated tolerance to malaria simultaneously impairs resistance to S. typhimurium. We propose (Fig. 6 ) that during acute hemolysis, heme triggers immediate mobilization of granulocytes from bone marrow to blood and generation of ROS 16 , while simultaneously inducing HO-1 in immature myeloid cells and thereby reducing their subsequent oxidative burst capacity 30, 33 , perhaps by limiting the availability of heme for incorporation into NADPH oxidase 44 . This results in mobilization of a heterogeneous population of granulocytes with varying levels of oxidative burst capacity. During malaria infection, however, progressive hemolysis leads to sustained release of free heme, which both impairs maturation of the oxidative burst capacity of granulocytes in the bone marrow and mobilizes functionally immature granulocytes from bone marrow into the peripheral circulation. Accumulation in peripheral blood of functionally impaired granulocytes, which phagocytose but are unable to kill bacteria, provides a new niche for bacterial replication and dissemination. In this scenario, HO-1 contributes to impaired resistance to NTS, but heme also has a direct role-either in granulocyte mobilization 16 or as a substrate for HO-1. The heme degradation products carbon monoxide, biliverdin and iron may further impair resistance to NTS by reducing production of ROS 21 or facilitating bacterial replication 45 . In contrast, nonheme induction of HO-1 (for example, by CoPP) may limit available iron for bacterial replication and protect phagocytic cells from apoptosis 45, 46 . Our observation that hemolysis specifically suppresses the oxidative burst capacity of neutrophils offers a plausible explanation for the particular susceptibility to NTS bacteremia in individuals with hemolysis. Salmonella species have evolved to survive and replicate inside mononuclear phagocytes 47 ; hemolysis provides an additional niche for sustained bacterial replication in circulating neutrophils. Our results are also consistent with studies of the cytoprotective role of HO-1 in mice; indeed, limitation of the granulocyte oxidative burst could be a key adaptive mechanism to reduce self-damage by ROS during hemolysis and to prevent tissue injury associated with release of heme.
Very few mechanisms have been clearly identified that confer tolerance to the harm caused by infectious organisms 48 , despite recent interest in the therapeutic potential of augmenting host tolerance 49 . In mice, HO-1 confers tolerance to blood-stage malaria 24, 25 but simultaneously diminishes resistance to malaria parasites developing in the liver 50 , whereas in Drosophila, infection-induced anorexia increases tolerance against S. typhimurium but reduces resistance against Listeria monocytogenes 51 , indicating that resistance and tolerance mechanisms can be highly pathogen specific and that a mechanism of tolerance to one pathogen can diminish resistance to another. Although it is well recognized that co-infection with different pathogens can enhance disease severity, and in some cases molecular mechanisms have been elucidated 52 , to our knowledge, this study provides the first direct evidence in a mammalian model of tolerance to one pathogen impairing resistance to another.
To conclude, our findings have a number of key implications. First, they provide an explanation for the susceptibility to NTS bacteremia in individuals with malaria and sickle cell disease. Second, they imply 
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that tolerance and resistance mechanisms identified from studies of single pathogens may not easily translate to the 'real world' , where people are simultaneously exposed to multiple pathogens. Specifically, the concept that the cytoprotective effects of HO-1 may be harnessed by administering its products therapeutically in humans without adversely affecting host defense against infection 53, 54 may not be valid. Third, we have identified a potential adjunct therapy (SnPP) that might enhance resistance to NTS in patients with hemolytic diseases. SnPP has been used experimentally to prevent severe jaundice 55 , but optimization of treatment would be crucial to avoid impairment of tolerance to heme. The experimental system described here may be a good starting point to assess and optimize such treatments.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/. Figure 6 Proposed mechanism to explain how hemolysis impairs resistance to S. typhimurium through heme-and heme oxygenase-dependent dysfunctional granulocyte mobilization.
(a-c) Proposed scheme for granulocyte mobilization in response to S. typhimurium infection (a) and the dysfunctional mobilization induced by hemolysis (b), which causes impaired resistance to S. typhimurium (c).
In normal C57BL/6 mice (a), S. typhimurium infection causes emergency granulopoiesis (1) and mobilization of granulocytes from bone marrow (2) . These granulocytes are able to phagocytose S. typhimurium and generate a normal oxidative burst, controlling bacterial replication (3). (b) Intravascular hemolysis caused by malaria or phenyhydrazine treatment liberates hemoglobin and hemoglobin-derived heme. Heme induces HO-1 expression in immature myeloid cells (4), and heme is degraded to biliverdin, carbon monoxide and iron (inset). These heme degradation products may modify the function of developing granulocytes. Heme also causes mobilization of mature granulocytes from bone marrow (5) and may activate the oxidative burst (6) . However, in chronic hemolysis (as in the case of Py17XNL infection), functionally immature granulocytes accumulate in the blood, ultimately resulting in reduced oxidative burst capacity (7) . (c) The combination of hemolysis and S. typhimurium challenge increases mobilization of bone marrow granulocytes with low oxidative burst capacity and high cellular iron stores into the blood. These granulocytes are able to phagocytose S. typhimurium normally but are unable to kill the bacteria, owing to low oxidative burst capacity, and support bacterial growth due to the high iron availability, ultimately allowing increased bacterial replication and dissemination (8) . Flow cytometry. Antibodies used are described in the Supplementary Methods. We performed intracellular staining for HO-1 on the basis of a previously described method 56 .
Microscopy. Chamber slides were protected from light and air-dried for 2 h before nuclear staining and mounting with DAPI dissolved in confocal matrix. To determine whether bacteria were intracellular or adherent to the cell surface, we assessed cells with overlapping GFP + S. typhimurium by 0.5-µm interval Z-stack imaging. For light microscopy, we fixed thin blood films with methanol and air dried before staining with May-Grünwald Giemsa stain.
Salmonella phagocytosis and killing assays.
We assessed ex vivo phagocytosis and killing of S. typhimurium in a gentamicin protection assay and quantified by flow cytometry (staining with allophycocyanin-conjugated antibody against Gr-1 (eBioscience) and phycoerythrin-Cy7-conjugated antibody against CD11b (eBioscience)), confocal microscopy and bacterial culture. We seeded isolated CD11b + cells at 1 × 10 5 per well in flat-bottomed 96-well plates or at 2 × 10 5 per well in eight-well chamber slides and incubated at 37 °C and 5% CO 2 for 20 min before addition of S. typhimurium at a multiplicity of infection (MOI) of ten S. typhimurium to one CD11b + cell. We determined phagocytosis at 45 min after infection and killing at 2 h after infection.
Oxidative burst and degranulation assay. We assessed neutrophil oxidative burst using a modification of a previously described flow cytometric assay 34 in which dihydrorhodamine 123 is converted to rhodamine. We measured neutrophil degranulation by the percentage increase in the median fluorescence intensity of surface CD11b expression in stimulated versus unstimulated samples.
Measurement of heme and hemoglobin. We determined concentrations of hemin and hemoglobin using Quantichrom Heme and Hemoglobin assay kits (BioAssay Systems). We quantified protein-bound plasma heme using a previously described spectrophotometric method 57 and the concentration of plasma hemoglobin using a previously published method 58 .
Hmox1 expression and HO activity assays. We determined Hmox1 mRNA expression in liver by quantitative RT-PCR. We standardized cDNA expression for each sample using the housekeeping genes Gapdh and Tbp and calculated expression as relative fold change compared to healthy control samples. We measured HO activity in whole-liver homogenates after red blood cell lysis using a previously described method 59 . We measured plasma HO-1 by ELISA using an HO-1 Immunoset (Enzo Life Sciences).
Statistical analyses.
We performed statistical analysis using Graph Pad Prism 5 software. We used an alpha value of 0.05 for all preplanned statistical analyses. We used the log-rank Mantel Cox test for survival analysis. We analyzed continuous data that were approximately normally distributed using two-sided unpaired or paired Student's t test for pairwise comparisons or one-way ANOVA with post hoc testing using Dunnett's multiple comparison test for comparison with the control group, Tukey's multiple comparison test for comparison between multiple groups and Bonferroni's multiple comparison test for comparison between two or more selected pairs. We log 10 -transformed all data relating to bacterial loads before analysis. We compared proportions between groups using Fisher's exact test.
Additional methods. Detailed methodology is described in the Supplementary Methods. 
